Mounjaro: miracle or curse?
Mounjaro is a relatively new medication, approved in 2022 for the treatment of type 2 diabetes. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, which work by increasing insulin secretion and decreasing glucagon secretion. Mounjaro is an injectable prescription medicine that adults with […]
Read More